L M Shulman

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi request reprint Non-recognition of depression and other non-motor symptoms in Parkinson's disease
    L M Shulman
    Department of Neurology, University of Maryland School of Medicine, 22 S Greene Street, Baltimore, MD 21201, USA
    Parkinsonism Relat Disord 8:193-7. 2002
  2. ncbi request reprint Comorbidity of the nonmotor symptoms of Parkinson's disease
    L M Shulman
    Department of Neurology, University of Maryland School of Medicine, 22 S. Greene St, Baltimore, MD 21201, USA
    Mov Disord 16:507-10. 2001
  3. doi request reprint Psychogenic seizures and psychogenic movement disorders: are they the same patients?
    J L Hopp
    Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA
    Epilepsy Behav 25:666-9. 2012
  4. ncbi request reprint Cocaine-induced persistent dyskinesias
    W J Weiner
    Department of Neurology, University of Maryland School of Medicine, Baltimore 21201, USA
    Neurology 56:964-5. 2001
  5. ncbi request reprint When do patients with Parkinson disease disclose their diagnosis?
    S Haines
    Department of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Neurology 67:488-90. 2006
  6. doi request reprint Istradefylline as monotherapy for Parkinson disease: results of the 6002-US-051 trial
    H H Fernandez
    Department of Neurology, University of Florida Movement Disorders Center, PO Box 100236, 100 South Newell Dr, L3 100, Gainesville, FL 32610 0236, USA
    Parkinsonism Relat Disord 16:16-20. 2010
  7. ncbi request reprint Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology
    J M Miyasaki
    University of Toronto, Canada
    Neurology 66:996-1002. 2006

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Non-recognition of depression and other non-motor symptoms in Parkinson's disease
    L M Shulman
    Department of Neurology, University of Maryland School of Medicine, 22 S Greene Street, Baltimore, MD 21201, USA
    Parkinsonism Relat Disord 8:193-7. 2002
    ..Depression, anxiety, fatigue and sleep disorders occur commonly in patients with Parkinson's disease (PD). These non-motor symptoms often contribute to the reduction of functional abilities in PD patients...
  2. ncbi request reprint Comorbidity of the nonmotor symptoms of Parkinson's disease
    L M Shulman
    Department of Neurology, University of Maryland School of Medicine, 22 S. Greene St, Baltimore, MD 21201, USA
    Mov Disord 16:507-10. 2001
    ..These results suggest that recognition of these diverse nonmotor symptoms may be enhanced by looking for others when one nonmotor symptom has been identified...
  3. doi request reprint Psychogenic seizures and psychogenic movement disorders: are they the same patients?
    J L Hopp
    Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA
    Epilepsy Behav 25:666-9. 2012
    ..These similar profiles suggest that PNES and PMD may not be distinct or separate entities and that collaborative investigative efforts and management are warranted...
  4. ncbi request reprint Cocaine-induced persistent dyskinesias
    W J Weiner
    Department of Neurology, University of Maryland School of Medicine, Baltimore 21201, USA
    Neurology 56:964-5. 2001
    ..The abnormal movements and behavior disorder persisted after a 20-month cocaine-free period...
  5. ncbi request reprint When do patients with Parkinson disease disclose their diagnosis?
    S Haines
    Department of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Neurology 67:488-90. 2006
    ..Patients who delayed disclosure were more likely male, younger, and employed. There is considerable variability among patients with PD in the time to disclose their diagnosis...
  6. doi request reprint Istradefylline as monotherapy for Parkinson disease: results of the 6002-US-051 trial
    H H Fernandez
    Department of Neurology, University of Florida Movement Disorders Center, PO Box 100236, 100 South Newell Dr, L3 100, Gainesville, FL 32610 0236, USA
    Parkinsonism Relat Disord 16:16-20. 2010
    ..6002-US-051 was a 12-week, double-blind study evaluating the safety and efficacy of istradefylline, a selective A(2A) adenosine receptor antagonist, as monotherapy in patients with Parkinson's disease (PD)...
  7. ncbi request reprint Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology
    J M Miyasaki
    University of Toronto, Canada
    Neurology 66:996-1002. 2006
    ..1) What tools are effective to screen for depression, psychosis, and dementia in PD? 2) What are effective treatments for depression and psychosis in PD? 3) What are effective treatments for PD dementia or dementia with Lewy bodies (DLB)?..